Executive Director, Clinical Development

GEMMABio

Philadelphia (Philadelphia County)

On-site

USD 210,000 - 320,000

Full time

20 hours ago
Be an early applicant

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

GEMMABio is seeking an Executive Director, Clinical Development to lead the clinical strategy for a portfolio of gene therapy programs across neuromuscular, cardiovascular, oncology, metabolic and infectious diseases. You will oversee the design and execution of CDPs and studies from first-in-human through late-phase development.

The ideal candidate has an MD with 5–7 years in clinical drug development, global regulatory submissions experience, and a proven leadership record in rare diseases and

Qualifications

  • MD minimum; 5–7 years in clinical drug development.
  • Experience leading Phase 1–4 programs in pharma/biotech.
  • Proven regulatory submissions experience (INDs, NDAs, MAAs).
  • Experience with rare diseases and gene therapies preferred.

Responsibilities

  • Provide tactical oversight of clinical development across all phases.
  • Lead protocol design, study documents, and CRFs with cross-functional teams.
  • Represent clinical development in external meetings with regulators and partners.
  • Oversee safety data review, pharmacovigilance, and data interpretation.

Skills

Clinical development oversight
Regulatory knowledge
Leadership
KOL/investigator liaison
GCP/IND submissions

Education

MD degree

Job description

If you are unable to complete this application due to a disability, contact this employer to ask for an accommodation or an alternative application process.

Executive Director, Clinical Development

Clinical Full Time

GEMMABio is advancing a diverse portfolio of gene therapy programs across multiple therapeutic areas, including neuromuscular, cardiovascular, oncology, metabolic, and infectious diseases.

Summary

Reporting to the Chief Medical Officer, (CMO) The Executive Director, Clinical Development, will provide tactical oversight for the clinical/medical aspects of all phases of the clinical drug development process. The Executive Director will be involved in the design, development and execution of Clinical Development Plans (CDPs), clinical trials and protocols in accordance with Good Clinical Practice (GCP) regulations. The person will lead and contribute to the analysis of study results, the assessment of the extent to which the studies have achieved clinical, regulatory and commercial objectives and the documentation of study results.

As needed, the candidate may be assigned as the primary clinical/medical representative in meetings with external stakeholders, partners or other external audiences as needed. This includes, but may not be limited to, Key Opinion Leaders (KOLs), investigators, regulatory authorities, partners, vendors, consultants, etc. As needed, may author or review clinical/medical-related materials intended for external audiences.

  • Contributes to, reviews and approves study protocols, protocol amendments, study manuals, Investigator Brochures (IBs), Clinical Study Reports (CSRs), Informed Consent Forms (ICFs), Case Report Forms (CRFs) and other clinical documents as required for the conduct of clinical trials.
  • Participates in KOL and investigator sites selection for inclusion in study/studies.
  • Prepare weekly and/or monthly study update reports which contain detailed information on enrollment data and adverse events as well as other general information relating to the progress of the study.
  • Interprets, summarizes and documents clinical data for CSRs, regulatory documents (e.g. INDs, Annual Reports, NDAs, MAAs, etc.) manuscripts, promotional material and other publications as required.
  • Serve as an early stage clinical development lead and expected to partner with Translational Research unit to ensure clinical input is integrated in nonclinical and NHP studies to support TPP.
  • Clinical Strategy – In partnership with Chief Medical Officer (CMO), support the clinical development strategy for programs targeting rare and ultra rare neurodegenerative genetic disorders
  • Trial Design and Execution – Lead activities related to Phase 1-4 clinical trials to deliver on the strategic vision and address patient needs (e.g., authoring and reviewing protocols, investigator brochures, and clinical study reports; CRO management).
  • Medical Monitoring oversight– Define, plan, and provide dedicated medical monitoring support, including the evaluation of participant eligibility, safety, and efficacy across ongoing and completed studies in Neuromuscular, CNS, Metabolic & other rare disease designated focus areas.
  • Pharmacovigilance & Data Analysis – Review adverse events, monitor real-time safety data, prepare analyses and clinical input for regulatory submissions, and lead data interpretation in partnership with pharmacovigilance CRO partners
  • DMC & Safety Governance – May serve as a clinical representative for Data Monitoring Committee (DMC) safety reviews, evaluating potential dose-limiting toxicities and ensuring CRO pharmacovigilance oversight across the clinical portfolio.

Qualifications

  • MD degree is (preferred) and a minimum of 5-7 years of clinical drug development experience in a pharmaceutical, biotechnology or related environment.
  • Clinical development oversight experience in Latin America, EU and MENA region (preferred)
  • Experience in pediatric neurology or neuromuscular neurology
  • An American Board of Psychiatry and Neurology (ABPN) (Preferred)
  • Demonstrated expertise in the clinical development of therapies across all phases of development (Phase 1-4), with a strong understanding of regulatory requirements and global drug development processes for rare diseases & AAV gene editing based programs
  • Proven ability to lead the design, execution, medical oversight, and interpretation of clinical trials, including study protocol development, endpoint selection, safety monitoring, and data analysis.
  • Hands-on experience preparing and supporting regulatory submissions and health authority interactions, including INDs, CTAs, briefing documents, orphan drug applications, and BLA/MAA-enabling activities.
Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Executive Medical Director, Neurology, Clinical Development
Executive Medical Director, Neurology, Clinical Development

Katalyst CRO • Bridgewater (MA)

On-site
USD 250,000 - 350,000
Executive Director, Clinical Development — Gene Therapy
Executive Director, Clinical Development — Gene Therapy

GEMMABio • Philadelphia

On-site
USD 210,000 - 320,000
Associate Director, Program Management
Associate Director, Program Management

GEMMABio • Philadelphia

On-site
USD 150,000 - 230,000
Senior Medical Director
Senior Medical Director

HW3 • United States

On-site
USD 240,000 - 420,000
Vice President, Clinical Development
Vice President, Clinical Development

Trimaren Human Capital Partners • Watertown (MA)

On-site
USD 250,000 - 420,000
Executive Medical Director, Clinical Development - M.D. (Nephrology)
Executive Medical Director, Clinical Development - M.D. (Nephrology)

Clinical Dynamix, Inc. • Jersey City (NJ)

On-site
USD 250,000 - 370,000
Associate Director, Program Management
Associate Director, Program Management

ADP, Inc. • Philadelphia

On-site
USD 150,000 - 190,000
Executive Director, Clinical Development - Immunology (MD)
Executive Director, Clinical Development - Immunology (MD)

Neurocrine Continental • San Diego (CA)

On-site
USD 250,000 - 380,000
Senior Medical Director, Clinical Development
Senior Medical Director, Clinical Development

Stratacuity: Proven Scientific Placement • Boston (MA)

On-site
USD 200,000 - 250,000
Medical Director – Clinical Development – Neurology
Medical Director – Clinical Development – Neurology

Green Key Resources LLC • Waltham (MA)

Hybrid
USD 180,000 - 280,000